A multi-scale semi-mechanistic CK/PD model for CAR T-cell therapy.

Area of Science:

• Immunotherapy
• Pharmacodynamics
• Mathematical Modeling

Background:

• Chimeric antigen receptor T (CAR T) cell therapy shows promise for hematologic malignancies.
• CAR T cell therapy exhibits unique cellular kinetics (CK) and pharmacodynamic (PD) behavior due to its living nature.
• CK is characterized by expansion, contraction, and persistence, intrinsically linked to target binding.

Purpose of the Study:

• To develop a semi-mechanistic model for CAR T cell CK/PD.
• To incorporate molecular binding, T cell phenotypes, and tumor dynamics.
• To analyze factors influencing CAR T cell therapy response and efficacy.

Main Methods:

• Developed a semi-mechanistic model for CAR T cell CK/PD.
• Integrated molecular binding, T cell dynamics (multiple phenotypes), and tumor growth/killing.
• Calibrated the model using published CD19-targeting CAR T cell therapy data.

Main Results:

• The model successfully captured CAR T cell CK and PD.
• Sensitivity analysis revealed patient- and drug-specific factors influencing response variability.
• Explored the impact of tumor characteristics on CAR T cell expansion and efficacy.

Conclusions:

• The developed model provides a framework for understanding CAR T cell therapy behavior.
• The model can predict response variability and optimize therapeutic strategies.
• Further research can refine the model for personalized CAR T cell therapy.